In this video, Pashalina Kehagias discusses how an early increase in ctDNA may predict a poor response to regorafenib in advanced CRC.
Pashalina Kehagias
Advertisement
Articles by Pashalina Kehagias
Advertisement
Latest Updated Articles
ctDNA Increase May Predict Regorafenib Response in Advanced CRCPublished: April 25th 2018 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
How Will ESMO 2025 Data Shape the Future of Genitourinary Cancer Care?
2
Exploring the ESMO 2025 Presentations That May Shift GU Oncology
3
FDA Grants FTD to Novel Cancer Vaccine in Low Tumor Burden Follicular Lymphoma
4
Pembrolizumab/Chemotherapy Improves Survival in Recurrent PROC
5
